Nuclear translocation of β-catenin protein but absence of β-catenin and APC mutation in gastrointestinal carcinoid tumor

Annals of Surgical Oncology

Volumn 13, Issue 12, 2006, Pages 1604-1609

  Su, Min Cheng ^a   Wang, Chia Chi ^b   Chen, Chun Chin ^a   Hu, Rey Heng ^c   Wang, Ting Huang ^c   Kao, Hsin Lien ^c   Jeng, Yung Ming ^c   Yuan, Ray Hwang ^c  

^a MIN SHENG GENERAL HOSPITAL   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

catenin mutation; APC mutation; Carcinoid tumors

Indexed keywords

APC PROTEIN; BETA CATENIN; WNT PROTEIN;

ARTICLE; CARCINOID; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPLASM; EXON; GASTROINTESTINAL TUMOR; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENE TRANSLOCATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN ANALYSIS; SEQUENCE ANALYSIS;

ADENOMATOUS POLYPOSIS COLI PROTEIN; BETA CATENIN; CARCINOID TUMOR; CELL NUCLEUS; CYTOPLASM; EXONS; GASTROINTESTINAL NEOPLASMS; HUMANS; MUTATION; PROTEIN TRANSPORT; SUBCELLULAR FRACTIONS;

EID: 33845677703     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9072-2     Document Type: Article

References (35)

1. Bornstein-Quevdo L, Gamboa-Dominguez A. Carcinoid tumour of the duodenum and ampulla of Vater: a clinicomorphologic, immunohistochemical, and cell kinetic comparison. Hum Pathol 2001; 32:1252-6.
2. Hartel M, Wente MN, Sido B, Friess H, Buchler MW. Carcinoid of the ampulla of Vater. J Gastroenterol Hepatol 2005; 20:676-81.
3. Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current status of gastrointestinal carcinoids. Gastroenterology 2005; 128:1717-51.
4. Soga J. Carcinoids and their variant endocrinomas: an analysis of 11842 reported cases. J Exp Clin Cancer Res 2003; 22:517-30.
5. Kulke MH, Mayer RJ. Carcinoid tumors. N Engl J Med 1999; 340:858-68.
6. Modlin IM, Shapiro MD, Kidd M. An analysis of rare carcinoid tumors: clarifying these clinical conundrums. World J Surg 2005; 29:92-101.
7. Williams ED, Sandler M. The classification of carcinoid tumors. Lancet 1963; 1:238-9.
8. Solcia E, Kloppel G, Sobin LH. Histological typing of endocrine tumours. In: WHO International Histological Classification of Tumours. Berlin: Springer, 2000; pp 56-74.
9. Ozawa M, Baribault H, Kemler R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 1989; 8:1711-7.
10. Bienz M. β-Catenin: a pivot between cell adhesion and Wnt signalling. Curr Biol 2005; 15:R64-7.
11. Rubinfeld B, Souza B, Albert I, et al. Association of the APC gene product with β-catenin. Science 1993; 262:1731-4.
12. Su LK, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993; 262:1734-7.
13. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 1996; 272:1023-6.
14. Orford K, Crockett C, Jensen JP, Weissman AM, Byers SW. Serine phosphorylation-regulated ubiquitination and degradation of β-catenin. J Biol Chem 1997; 272:24735-8.
15. Behrens J, von Kries JP, Kuhl M, et al. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 1996; 382:638-42.
16. Huber O, Korn R, McLaughlin J, Ohsugi M, Herrmann BG, Kemler R. Nuclear localization of β-catenin by interaction with transcription factor LEF-1. Mech Dev 1996; 59:3-10.
17. Funayama N, Fagotto F, McCrea P, Gumbiner BM. Embryonic axis induction by the armadillo repeat domain of β-catenin: evidence for intracellular signaling. J Cell Biol 1995; 128:959-68.
18. Yost C, Torres M, Miller JR, Huang E, Kimelman D, Moon RT. The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev 1996; 10:1443-54.
19. Behrens J, Lustig B. The Wnt connection to tumorigenesis. Int J Dev Biol 2004; 48:477-87.
20. Morin PJ, Sparks AB, Korinek V, et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997; 275:1787-90.
21. Moreno-Bueno G, Hardisson D, Sanchez C, et al. Abnormalities of the APC/β-catenin pathway in endometrial cancer. Oncogene 2002; 21:7981-90.
22. Oliva E, Sarrio D, Brachtel EF, et al. High frequency of beta-catenin mutations in borderline endometrioid tumours of the ovary. J Pathol 2006; 208:708-13.
23. Hsu HC, Jeng YM, Mao TL, Chu JS, Lai PL, Peng SY. β-Catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. Am J Pathol 2000; 157:763-70.
24. Jeng YM, Wu MZ, Mao TL, Chang MH, Hsu HC. Somatic mutations of β-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma. Cancer Lett 2000; 152:45-51.
25. Tejpar S, Nollet F, Li C, et al. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 1999; 18:6615-20.
26. Fujimori M, Ikeda S, Shimizu Y, Okajima M, Asahara T. Accumulation of β-catenin protein and mutations in exon 3 of β-catenin gene in gastrointestinal carcinoid tumor. Cancer Res 2001; 61:6656-9.
27. Cadigan KM, Liu YI. Wnt signaling: complexity at the surface. J Cell Sci 2006; 119:395-402.
28. Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J 1998; 17:1371-84.
29. Ozaki S, Ikeda S, Ishizaki Y, et al. Alterations and correlations of the components in the Wnt signaling pathway and its target genes in breast cancer. Oncol Rep 2005; 14:1437-43.
30. Odajima T, Sasaki Y, Tanaka N, et al. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features. Hum Pathol 2005; 36:234-41.
31. Saldanha G, Ghura V, Potter L, Fletcher A. Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation. Br J Dermatol 2004; 151:157-64.
32. Semba S, Kusumi R, Moriya T, Sasano H. Nuclear accumulation of β-catenin in human endocrine tumors: association with Ki-67 (MIB-1) proliferative activity. Endocrin Pathol 2000; 11:243-50.
33. Mao TL, Chu JS, Jeng YM, Lai PL, Hsu HC. Expression of mutant nuclear β-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis. J Pathol 2001; 193:95-101.
34. Huang H, Fujii H, Sankila A, et al. Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am J Pathol 1999; 155:1795-801.
35. Pelosi G, Scarpa A, Puppa G, et al. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Cancer Lett 2005; 103:1154-64.